Home › Funds › Alpha Wave Global, LP › ANRO
Alpha Wave Global, LP position in ANRO
ALTO NEUROSCIENCE INC · Health Care
Alpha Wave Global, LP reported holding 3,707,757 shares of ANRO (ALTO NEUROSCIENCE INC) in its Q3 2026 13F filing — a position valued at US$94.7M, representing 2.30% of its reported portfolio and ranking #4 among its reported holdings. Alpha Wave Global, LP has disclosed ANRO holdings in 11 of the last 11 reported quarters, going back to Q1 2024.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How Alpha Wave Global, LP's ANRO position evolved
Alpha Wave Global, LP first disclosed a stake in ANRO in Q1 2024 at 3,707,757 shares (US$56.9M). The position peaked in Q2 2026 at 3,707,757 shares, worth US$97.8M. Across 11 filings, Alpha Wave Global, LP held the position steady without any share-count change. The most recent filing (Q3 2026) shows 3,707,757 shares valued at US$94.7M.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 3.71M | $56.91M | New |
| Q2 2024 | 3.71M | $39.64M | Hold |
| Q3 2024 | 3.71M | $42.42M | Hold |
| Q4 2024 | 3.71M | $15.68M | Hold |
| Q1 2025 | 3.71M | $8.01M | Hold |
| Q2 2025 | 3.71M | $8.16M | Hold |
| Q3 2025 | 3.71M | $14.91M | Hold |
| Q4 2025 | 3.71M | $66.00M | Hold |
| Q1 2026 | 3.71M | $83.35M | Hold |
| Q2 2026 | 3.71M | $97.85M | Hold |
| Q3 2026 | 3.71M | $94.66M | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About ANRO and 13F data
ANRO (ALTO NEUROSCIENCE INC) is a Health Care company. 62 other funds we track also report a position in ANRO — the largest reported positions include Commodore Capital LP (US$71.9M), Spruce Street Capital LP (US$42.8M), PERCEPTIVE ADVISORS LLC (US$42.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding ANRO
- Commodore Capital LP 2.72M sh · $71.87M · Q2 2026
- Spruce Street Capital LP 1.68M sh · $42.80M · Q3 2026
- PERCEPTIVE ADVISORS LLC 1.61M sh · $42.49M · Q2 2026
- Vivo Capital, LLC 1.36M sh · $34.72M · Q3 2026
- ARMISTICE CAPITAL, LLC 864.00K sh · $22.80M · Q2 2026
- Vestal Point Capital, LP 785.00K sh · $20.72M · Q2 2026
- 72 Investment Holdings, LLC 667.78K sh · $17.62M · Q2 2026
- Affinity Asset Advisors, LLC 643.34K sh · $16.42M · Q3 2026
- Venrock Adviser, LLC 500.00K sh · $13.20M · Q2 2026
- Parkman Healthcare Partners LLC 429.04K sh · $11.32M · Q2 2026
- Ikarian Capital, LLC 407.34K sh · $10.75M · Q2 2026
- Saturn V Capital Management LP 182.83K sh · $4.82M · Q2 2026
More on Alpha Wave Global, LP
FAQ
How long has Alpha Wave Global, LP held ANRO?
Alpha Wave Global, LP has disclosed ANRO holdings in 11 of the last 11 reported quarters, going back to Q1 2024.
What is Alpha Wave Global, LP's current position in ANRO?
As of Q3 2026, Alpha Wave Global, LP holds 3.71M shares of ANRO (ALTO NEUROSCIENCE INC), valued at $94.66M, representing 2.30% of its reported portfolio and ranking #4.
Has Alpha Wave Global, LP been buying or selling ANRO?
In the latest 13F filing (Q3 2026), Alpha Wave Global, LP held unchanged its position in ANRO. The position peaked in Q2 2026 at 3.71M shares.
Which other funds hold ANRO?
Other major institutional holders of ANRO include Commodore Capital LP, Spruce Street Capital LP, PERCEPTIVE ADVISORS LLC, among 62 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.